References
- Allen TM. (1994). The use of glycolipids and hydrophilic polymers in avoiding rapid uptake of liposomes by the mononuclear phagocyte system. Adv Drug Deliv Rev 13:285–309.
- Cohen ZR, Ramishetti S, Peshes-Yaloz N, et al. (2015). Localized RNAi therapeutics of chemoresistant grade iv glioma using hyaluronan-grafted lipid-based nanoparticles. ACS Nano 9:1581–91.
- Hao NB, Lu MH, Fan YH, et al. (2012). Macrophages in tumor microenvironments and the progression of tumors. Clin Dev Immunol 2012:948098.
- Hayward SL, Wilson CL, Kidambi S. (2016). Hyaluronic acid-conjugated liposome nanoparticles for targeted delivery to CD44 overexpressing glioblastoma cells. Oncotarget 7:34158–71.
- Hu CMJ, Zhang L, Aryal S, et al. (2011). Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. Proc Natl Acad Sci USA 108:10980–5.
- Huang WC, Chen SH, Chiang WH, et al. (2016). Tumor microenvironment-responsive nanoparticle delivery of chemotherapy for enhanced selective cellular uptake and transportation within tumor. Biomacromolecules 17:3883–92.
- Kim JE, Yoon IS, Cho HJ, et al. (2014). Emulsion-based colloidal nanosystems for oral delivery of doxorubicin: improved intestinal paracellular absorption and alleviated cardiotoxicity. Int J Pharm 464:117–26.
- Li WH, Yi XL, Liu X, et al. (2016). Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy. J Control Release 225:170–82.
- Li XY, Zhao Y, Sun MG, et al. (2014). Multifunctional liposomes loaded with paclitaxel and artemether for treatment of invasive brain glioma. Biomaterials 35:5591–604.
- Liu YY, Mei L, Yu QW, et al. (2015). Multifunctional tandem peptide modified paclitaxel-loaded liposomes for the treatment of vasculogenic mimicry and cancer stem cells in malignant glioma. ACS Appl Mater Interfaces 7:16792–801.
- Liu Z, Xiong M, Gong JB, et al. (2014). Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment. Nat Commun 5:4280.
- Luo YP, Zhou H, Krueger J, et al. (2006). Targeting tumor-associated macrophages as a novel strategy against breast cancer. J Clin Invest 116:2132–41.
- Park Y, Pham TA, Beigie C, et al. (2015). Monodisperse micro-oil droplets stabilized by polymerizable phospholipid coatings as potential drug carriers. Langmuir 31:9762–70.
- Paulis YWJ, Huijbers EJM, van der Schaft DWJ, et al. (2015). CD44 enhances tumor aggressiveness by promoting tumor cell plasticity. Oncotarget 6:19634–46.
- Ruan S, Hu C, Tang X, et al. (2016). Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation. ACS Nano 10:10086–98.
- Schneider SW, Ludwig T, Tatenhorst L, et al. (2004). Glioblastoma cells release factors that disrupt blood–brain barrier features. Acta Neuropathol 107:272–6.
- Shao K, Ding N, Huang SX, et al. (2014). Smart nanodevice combined tumor-specific vector with cellular microenvironment-triggered property for highly effective antiglioma therapy. ACS Nano 8:1191–203.
- Shi KR, Long Y, Xu CQ, et al. (2015). Liposomes combined an integrin alpha(v)beta(3)-specific vector with pH-responsible cell-penetrating property for highly effective antiglioma therapy through the blood–brain barrier. ACS Appl Mater Interfaces 7:21442–54.
- Song ML, Liu T, Shi CR, et al. (2016). Bioconjugated manganese dioxide nanoparticles enhance chemotherapy response by priming tumor-associated tL.A macrophages toward M1-like phenotype and 11 attenuating tumor hypoxia (vol 10, pg 633, 2016). ACS Nano 10:3872.
- Song SS, Chen F, Qi H, et al. (2014). Multifunctional tumor-targeting nanocarriers based on hyaluronic acid-mediated and pH-sensitive properties for efficient delivery of docetaxel. Pharm Res 31:1032–1045.
- Vescovi AL, Galli R, Reynolds BA. (2006). Brain tumour stem cells. Nat Rev Cancer 6:425–436.
- Wang DY, Gu YX, Li YQ, et al. (2015). Detection of CD133 expression in U87 glioblastoma cells using a novel anti-CD133 monoclonal antibody. Oncol Lett 9:2603–2608.
- Yamada K, Ushio Y, Hayakawa T, et al. (1982). Quantitative autoradiographic measurements of blood-brain-barrier permeability in the rat glioma model. J Neurosurg 57:394–398.
- Yang S, Gao HL. (2017). Nanoparticles for modulating tumor microenvironment to improve drug delivery and tumor therapy. Pharmacol Res 126:97–108.
- Yang XY, Li YX, Li M, et al. (2013). Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Cancer Lett 334:338–345.
- Zhang SW, Zhang DF, Sun BC. (2007). Vasculogenic mimicry: current status and future prospects. Cancer Lett 254:157–164.